Teradyne Inc., US8807701029

Teradyne stock trades on earnings and guidance context

Published on 07/18/2026 at 14:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Teradyne stock tracks the latest quarterly context, with the company pointing to $684.8 million in first-quarter 2026 revenue and $0.75 adjusted EPS on 29 April 2026.

Bunte Pop-Art-Comicillustration eines Technikers an einer Halbleiter-Testmaschine
Pop-Art-Comicszene mit Testmaschine und Roboterarm vermittelt die Innovationskraft von Teradyne Inc. US8807701029 verspielt, Illustration mit AI erstellt.

Teradyne Inc. (US8807701029) is being read through its latest reported numbers, including $684.8 million in first-quarter 2026 revenue and adjusted EPS of $0.75, both disclosed on 29 April 2026. The company said those figures came alongside a 3.1% year-over-year revenue increase and a stronger earnings base than the prior quarter.

Revenue up 3.1%

The first-quarter 2026 revenue of $684.8 million marked a 3.1% increase from the same period a year earlier, while adjusted EPS of $0.75 provides the clearest recent profit marker for Teradyne stock. Those two numbers give investors a more concrete read on operating momentum than a generic semiconductor-cycle view.

For a market that often prices test-equipment names against cycle timing, the combination of $684.8 million in sales and $0.75 adjusted EPS matters because it ties valuation to a dated report rather than a theme. The quarterly release dated 29 April 2026 is the freshest anchor available in the company record.

Cycle and margin focus

Teradyne also framed the quarter around continued demand in automation and semiconductor test, which helped support the year-over-year comparison. The 3.1% revenue gain is modest in absolute terms, but it still shows that the business is not standing still quarter to quarter.

Because the company did not pair the quarter with a headline-grabbing acquisition or restructuring, the operating mix is the central story. That leaves revenue, EPS, and the quarter-to-quarter progression as the main evidence points for assessing the shares.

Read deeper

Teradyne first-quarter 2026 results

The companys latest quarterly figures remain the core reference point for revenue, EPS, and operating trend.

Semiconductor test stays key

Teradyne’s core product mix remains tied to semiconductor test systems and automation equipment, which is why the quarterly revenue trend is more useful than a broad description of the company. The first-quarter 2026 update shows how much the stock still depends on execution in its test and robotics franchises.

That dependence also means small changes in customer demand can have an outsized effect on sentiment. A 3.1% sales rise in a single quarter does not solve the cycle question, but it does give the market a current data point to work with.

Quarterly numbers set the tone

Teradyne stock closed this article’s factual frame around the 29 April 2026 report, where the company posted $684.8 million in revenue and $0.75 adjusted EPS. The body of evidence rests on those dated figures, since no fresher company filing was used here.

For investors and traders, the most relevant issue is whether the next quarter can extend that 3.1% year-over-year revenue gain. Until then, the latest reported numbers remain the cleanest basis for judging the shares.

Teradyne stock facts

  • Company: Teradyne Inc.
  • ISIN: US8807701029
  • Ticker: NASDAQ: TER
  • Trading venue: NASDAQ
  • Sector / Industry: Technology / Semiconductor equipment
  • Index membership: S&P 500

Semiconductor test systems

Teradyne’s semiconductor test systems are the product line most closely tied to the company’s quarterly revenue pattern, and they remain the main commercial lens in this article. The first-quarter 2026 report placed that business in a wider operating context with revenue and EPS both dated 29 April 2026.

NASDAQ quote context

Teradyne stock is quoted on NASDAQ under TER, and the latest report date used here is 29 April 2026. The report numbers - $684.8 million in revenue and $0.75 adjusted EPS - are the latest evidenced anchors for the share narrative.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US8807701029 | TERADYNE INC. | boerse | 69795716 | bgmi